- Staat
- MI
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 08.05.2023
- Impfdatum
- 23.09.2022
- Beginn
- 14.04.2023
- Tage bis Beginn
- 203,0
- Dosis
- N/A
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute myocardial infarction
Angiogram cerebral abnormal
Arteriogram carotid abnormal
COVID-19
Cardiac failure congestive
Carotid artery disease
Cerebellar artery occlusion
Cerebral arteriosclerosis
Chest X-ray abnormal
Computerised tomogram head normal
Cough
Cranial nerve disorder
Dyspnoea
Electrocardiogram change
Hypoxia
Lung disorder
Magnetic resonance imaging head abnormal
Mass
Symptomtext
Discharge Provider: Primary Care Provider: DO Admission Date: 4/14/2023 Discharge Date: Apr 20, 2023 PRESENTING PROBLEM: NSTEMI (non-ST elevated myocardial infarction) (HCC) HOSPITAL COURSE: 93-year-old female with a known history of hyperlipidemia, anxiety disorder, reflux presented to the Emergency Room 04/14/2023 with a week's worth of shortness of breath that had been progressing. Was found to be hypoxic in the emergency room requiring 3 L nasal cannula oxygen. Normally on room air at home. The patient tested positive for COVID and was started on remdesivir and dexamethasone. Troponins were elevated and cardiology consultation recommended transfer for echocardiogram and cardiology management. Elevated troponins 154 with repeat 139. Patient denied chest pain, but did have intermittent shortness of breath and cough. Chest x-ray was read as findings of CHF, bibasilar airspace disease and small pleural effusions, and proBNP was greater than 7000. Patient with improvement in her breathing with treatment for COVID. Cardiology consulted for elevated troponins and EKG changes, thought could be myocarditis related to COVID, recommended no further invasive evaluation. She also underwent a neurological workup for facial paresthesia. CT head without contrast showed no acute, CTA head and neck revealed no acute intracranial large vessel occlusion but severe short-segment atherosclerotic narrowing of the left anterior cerebral artery A2 segment and some minimal carotid artery disease. Parotid mass measuring 1.9 cm on the left. Has had this worked up and seen ENT 11/2022. Neurology consulted and patient underwent a brain MRI which revealed the left superior cerebellar artery appears to contact and bow the left cisternal trigeminal nerve near the root of entry zone, left anterior inferior cerebellar artery appears to exert mild mass effect upon left cranial nerve. Neurology recommended starting carbamazepine and will follow-up outpatient in clinic
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- 6,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hyperlipidemia GERD (gastroesophageal reflux disease) History of Helicobacter pylori infection Osteoarthritis of hand Osteoarthritis of hip Anxiety disorder Sciatica Dysphagia Hiatal hernia Glaucoma Allergic rhinosinusitis Nocturia Allergic conjunctivitis Osteoarthritis of spine DDD (degenerative disc disease), thoracolumbar Insomnia CVD (cerebrovascular disease) History of CVA (cerebrovascular accident) Chronic low back pain Essential hypertension Hypothyroidism, unspecified type Sigmoid diverticulosis Osteopenia Primary osteoarthritis of right hip History of esophageal stricture History of hiatal hernia Dyspnea COVID-19 virus infection Trigeminal nerve disorder AKI (acute kidney injury) (HCC) Myocarditis due to 2019 novel coronavirus
- Andere Medikamente
- albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler amLODIPine (NORVASC) 10 mg tablet ascorbic acid (VITAMIN C) 500 mg tablet atenolol (TENORMIN) 50 mg tablet atorvastatin (LIPITOR) 10 mg tablet BAYER ASPIR
- Allergien
- Bee VenomAnaphylaxis Simvastatin Sulfa Drugs
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 10.10.2022
- Impfdatum
- 03.10.2022
- Beginn
- 04.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Acute respiratory failure
Angiogram pulmonary abnormal
Asthenia
Atelectasis
Blood lactic acid normal
COVID-19
Chest X-ray abnormal
Confusional state
Full blood count normal
Hypotension
Hypoxia
Intensive care
Lung opacity
Metabolic function test normal
Pulmonary congestion
Pyrexia
SARS-CoV-2 test positive
Sepsis
Symptomtext
Discharge Provider: Primary Care Provider: Admission Date: 10/4/2022 Discharge Date: Oct 7, 2022 PRESENTING PROBLEM: Shock (HCC) [R57.9] Fever, unspecified fever cause [R50.9] Hypotension, unspecified hypotension type [I95.9] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present (HCC) [A41.9] Acute hypoxemic respiratory failure (HCC) [J96.01] HOSPITAL COURSE: 86-year-old female with asthma, chronic diastolic heart failure, history of complete heart block status post dual-chamber pacemaker, RA on chronic steroids presented to BW ED 10/4 due to weakness and confusion. On arrival to Emergency Department she was found to be febrile with temperature 39? C, hypoxic with oxygen saturation 88% on room air requiring 2 L nasal cannula supplementation. Patient remained hypotensive after receiving 1.9 L of NS and was started on NE. Chest x-ray revealed mild pulmonary vascular congestion. Complete blood count, BMP, urinalysis, and lactic acid were unremarkable. Found to be COVID positive. CT angio negative for PE; bibasilar atelectasis. Repeat CXR revealed hazy left lung base opacity. Patient started on antibiotics for possible bacteria pneumonia. Patient started on stress dose steroids, given on chronic steroids for her RA. Blood pressures improved, weaned off vasopressors. Increased pacemaker rate to 80bpm. Transferred out of ICU to Internal medicine service. Weaned off oxygen to RA. PT/OT evaluated patient and initially recommended SAR, but given improvement recommended home with HHC. Patient medically stable for discharge 10/7.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Moderate persistent asthma without complication; Female stress incontinence; RA (rheumatoid arthritis) (HCC)- Hyperlipidemia; Lichen planus; Vitamin B 12 deficiency; Atrioventricular block, complete (HCC); Chronic diastolic (congestive) heart failure (HCC); Cardiac pacemaker in situ; Mixed incontinence urge and stress (male)(female); Intrinsic sphincter deficiency (ISD); COVID-19 virus infection; Tremor.
- Andere Medikamente
- Albuterol (PROVENTIL, VENTOLIN, PROAIR) 108 (90 BASE) MCG/ACT inhaler Aspirin 81 MG EC tablet; Budesonide/formoterol (SYMBICORT) 160-4.5 MCG/ACT inhaler; Cefuroxime (CEFTIN) (Expired); Fluticasone (FLONASE) 50 MCG/ACT nasal spray; Hydrocodo
- Allergien
- Penicillins-Hives; Macrobid [Nitrofurantoin Monohydrate Macrocrystals]-Hives; Sulfa Drugs-Hives
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 27.10.2022
- Impfdatum
- 26.10.2022
- Beginn
- 26.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Loss of consciousness
Tremor
Symptomtext
She got her vaccine at 3:00 PM, and around 8:30 she got chills and had her regular clothes on, one bathroom, put on a 2nd longer and heavier bathrobe and her comforter. Later on she started shaking uncontrollably to the point that she was thinking of calling an ambulance. She remember around 9:30 she was watching TV and then blacked out or something and the chills went away, but the shaking then started. She stayed up for a couple of more hours and was OK. She was trying to read the reactions and could not as she was shaking so bad that she couldn't look them up or make chills. She went to bed around 2:00 AM and is OK this morning. She does believe that she did black out. She did not take anything for her symptoms. She is going to call her doctor this morning. Her arm is not red or hurting her.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Diabetes, high blood pressure, high cholesterol, hypothyroidism.
- Andere Medikamente
- Levothyroxine 75 mcg, Tioguicazone 30 mg, Lisinopril 40 mg, Glimepiride 2 mg, Metformin ER 1000 mg b.i.d., Metoprolol 50 twice a day, 81 mg aspirin twice a day, Vitamin B12 mcg, Vitamin D3 25 mcg, Natures Bounty for hair/skin/nails 2500 mcg
- Allergien
- Jardiance, Sulfa, Benadryl, Sudafed, Penicillin, Vitamin C, Cortisone. Food allergies: Vitamin C. Latex.
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 16.09.2022
- Impfdatum
- 16.09.2022
- Beginn
- 16.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fall
Loss of consciousness
Symptomtext
Patient received the shot and as he was walking out towards the door to leave he fell over near the exit where a worker was able to catch him. we followed patient to their car and he started passing out again but never fell completely, stayed with patient to ensure his safety.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- Patient refused any official medical help/ambulance. After sitting a while he was feeling fine to make it home
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Celexa, clonazepam, divalproex, donepezil, eliquis, memantine, metoprolol, omeprazole, potassium, tamsulosin
- Allergien
- No known drug allergies
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 97,0
- Geschlecht
- M
- Eingang
- 17.02.2023
- Impfdatum
- 05.10.2022
- Beginn
- 10.02.2023
- Tage bis Beginn
- 128,0
- Dosis
- N/A
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
COVID-19 pneumonia
Chills
Dyspnoea
Encephalopathy
Hypoxia
Mental status changes
Pneumonia
Pyrexia
Sepsis
Symptomtext
Discharge Provider: DO Primary Care Provider: MD Admission Date: 2/10/2023 Discharge Date: Feb 14, 2023 PRESENTING PROBLEM: Severe sepsis Acute COVID-19 COVID-19 Pneumonia due to COVID-19 virus HOSPITAL COURSE: 97-year-old male with past medical history of coronary artery disease, hypertension, hyperlipidemia, presented with fever, chills, shortness of breath and encephalopathy and found to have COVID -19 bilateral pneumonia. Patient was started on Decadron. Patient was placed on 2 L oxygen for mild hypoxia. He was given 2 L of IV fluid bolus in the emergency department. After admission, patient improved quite quickly and the next day his mental status was back to baseline, dyspnea resolved and his oxygen weaned off in the afternoon. Two days later, he was placed back on 2 L of oxygen due to mild hypoxia down to 86% on room air. Patient is asymptomatic and continues to feel well. His PT and OT initially recommended discharge to subacute rehab facility but with patient's improvement, the change the recommendation to discharging home with home health care and family assist. Patient was discharged home and to finish total of 10 days of Decadron on 02/14/2023
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- HTN (hypertension), benign Dyslipidemia BPH (benign prostatic hyperplasia) AI (aortic insufficiency) Nephrolithiasis Throat cancer Paraphimosis Elevated prostate specific antigen (PSA) - previous bx 1993 and 2002 - focal ASAP on 2002 biopsy Status post coronary artery stent placement Coronary artery disease involving native coronary artery of native heart without angina pectoris Benign non-nodular prostatic hyperplasia without lower urinary tract symptoms Primary hypothyroidism Elevated left diaphragm Chronic depression History of GI bleed History of pancreatitis Bladder outlet obstruction Bladder mass CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min Heart murmur GERD without esophagitis Chronic rhinitis Bladder cancer Chronic bronchitis, unspecified chronic bronchitis type History of bladder cancer Thrombocytopenia Decreased hearing of both ears Acute COVID-19 Myocardial injury Closed fracture of one rib of left side Pneumonia due to COVID-19 virus Acute respiratory failure with hypoxia
- Andere Medikamente
- amlodipine (NORVASC) 2.5 MG tablet Ascorbic Acid (VITAMIN C) 1000 MG tablet aspirin 81 MG tablet dexamethasone (DECADRON) 6 MG tablet escitalopram (LEXAPRO) 10 MG tablet fluticasone (FLONASE) 50 MCG/ACT nasal spray levothyroxine (SYNTHROID)
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 10.11.2022
- Impfdatum
- 10.11.2022
- Beginn
- 10.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Dyspnoea
Electrocardiogram abnormal
Flushing
Heart rate decreased
Symptomtext
patient given shot and then face started to get flushed and patient stating she was having more difficult time breathing. I called doctor in the room to assess the patient and then went and got an epipen out of the cabinet. We administered the epipen and within minutes the patient was feeling better and breathing easier. Still c/o of some difficulty breathing. O2 sat 99%. Emergency services called and transported the patient to the Emergency Room.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- EKG done on arrival to the ER due to heart rate dropping into the 40s.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- COPD, arthritis, DDD, esophageal spasm, HTN, osteoarthritis , RLS, smoker
- Andere Medikamente
- vicodin, albuterol, celecoxib, Vitamin D3, esomeprazole, HCTZ, hyoscyamine, lisinopril, magnesium amino acids chelate, pramipexole, spiriva.
- Allergien
- Relafen
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 21.10.2022
- Impfdatum
- 19.10.2022
- Beginn
- 19.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Blood test
Body temperature increased
Chest discomfort
Chills
Discomfort
Electrocardiogram
Fatigue
Feeling abnormal
Hypertension
Malaise
Muscle contractions involuntary
Symptomtext
At approximately 8:00 p.m., I began feeling unwell and uneasy in my skin. I went to bed and within about five minutes began to experience severe shivering and tight hard contractions in my jaw, hip, and abdomen. I tried to calm myself so that the shivering/contractions would abate, but they continued. After about ten minutes, I called to my husband for two ibuprofen, which I swallowed. I continued to experience the shivering for about twenty more minutes. My husband called the nurse who checked in with a doctor. I had a temperature of 101.3 I believe. A pulse oximeter revealed that my pulse rate ranged from 109 to 113. My pulse is usually quite low. My blood pressure was also high. Usually my blood pressure is low. The advice nurse thought that since my symptoms were diminishing that I was probably OK, so we hung up. About five minutes later I started to feel a pressure, tightening over my solar plexus, in the middle of my chest. This feeling did not go away; it was as if someone were pressing down firmly on the center of my chest. When this feeling didn't end after about fifteen minutes, my husband called nurse again. We spoke to the advice nurse and to the doctor who both strongly recommended/pressured us to check into Emergency Room. We were reluctant to do so knowing it meant for an exhausting night ahead, but we did. We arrived at Emergency between 10:30 and 11:00. I was given an EKG and then checked into a hospital room where I was given a second EKG. I stayed in that hospital room until I was released at approximately 6:00 a.m. on October 20. During my stay, I had my blood withdrawn and fluids administered--saline and electrolytes. I was given for aspirin to chew and swallow. Test results showed that I hadn't had a heart attack. Yay! The doctor said that my symptoms probably were a side effect of the vaccines. I returned home and slept from 7 a.m. until 6:00 a.m on October 21. I am currently exhausted but feeling much better.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypertension
- Hospital-Tage
- -
- Labordaten
- I don't know the exact names of the tests and results. I just know that blood was withdrawn, fluids administered, and that I didn't have a heart attack.
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 06.10.2022
- Impfdatum
- 06.10.2022
- Beginn
- 06.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Tremor
Symptomtext
Patient called to report experiencing tremors or uncontrollable shaking all over. Pharmacist recommended a visit to urgent care if not resolved in 15-20 minutes
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 88,0
- Geschlecht
- F
- Eingang
- 29.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 20.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dyspnoea
Tremor
Symptomtext
Began experiencing shortness of breath and shaking within 6 hours of receiving vaccine. Patient was admitted to hospital due to severe symptoms. Patient start feeling better and was released from hospital within 2 days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 1,0
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Yes, Pulmonary Fibrosis
- Andere Medikamente
- -
- Allergien
- No allergies
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 05.06.2023
- Impfdatum
- 29.09.2022
- Beginn
- 06.05.2023
- Tage bis Beginn
- 219,0
- Dosis
- N/A
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Atelectasis
Blood pressure systolic increased
COVID-19
Cardiac failure
Cardiac failure acute
Cardiac failure congestive
Computerised tomogram neck
Computerised tomogram thorax abnormal
Dysphagia
Exposure to SARS-CoV-2
Hypernatraemia
Hypophagia
Hypoxia
Left ventricular failure
Oesophageal stenosis
Patient isolation
Pharyngo-oesophageal diverticulum
Pyrexia
Symptomtext
5/6/2023 - 5/22/2023 (16 days) DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Elevated troponin Acute on chronic diastolic (congestive) heart failure (HCC) Acute congestive heart failure, unspecified heart failure type (HCC) HOSPITAL COURSE: 70-year-old woman with a history of CVA, heart failure preserved ejection fraction, hypertension, dysphagia, wheelchair-bound reported vascular dementia who presented on 05/06/2023 with poor intake over the preceding 4 days and troponin elevation in the setting of elevated systolic blood pressures after missing home medications. She was seen by speech pathology noted to have significant dysphagia with esophageal stricture and CT neck and thorax was performed which revealed zenker's diverticulum. GI was also consulted and recommended consultation with CTS before performing EGD, ultimately decided too high risk of perforation for EGD. Given her inability to take oral a corpak tube was placed to facilitate medications. CTS recommended outpatient follow up for endoscopic repair outpatient. They preferred cardiology optimization prior to this procedure, cardiology was consulted and obtained stress Echo which showed no evidence of ischemia. Patient did develop hypernatremia as well which improved with adjustment of free water flushes. Family was agreeable to PEG tube. IR was consulted and placed thison 5/15/2023 She developed hypoxia and left sided atelectasis. She also developed a fever. She tested positive for COVID 19 on film array. Her husband was a sick contact. She was started on Decadron which was discontinued after 2 days as she was not needing oxygen. She will need to stay in the hospital for a total of 10 days in isolation which will end on the 21st of May. She was discharge to assisted living facility stable on 5/22/2023
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- 16,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Osteoarthritis of multiple joints, unspecified osteoarthritis type Long term current use of systemic steroids H/O: CVA (cerebrovascular accident) GAD (generalized anxiety disorder) DM type 2 with diabetic peripheral neuropathy (HCC) Essential hypertension Overactive bladder At high risk for falls Requires assistance with activities of daily living (ADL) Hyperlipidemia, unspecified Rheumatoid arthritis involving multiple joints (HCC) Osteoporosis Hx of breast cancer History of gastric ulcer Vascular dementia with behavior disturbance (HCC) Elevated LFTs Advance care planning Hearing loss Chronic pain syndrome Chronic ulcer of right ankle limited to breakdown of skin (HCC) Dysphagia Cerumen debris on tympanic membrane, bilateral Edema of both lower extremities due to peripheral venous insufficiency At high risk for skin breakdown Zenker diverticulum Pulmonary nodule per CT 5/2023
- Andere Medikamente
- acetaminophen (TYLENOL) 500 mg tablet amLODIPine (NORVASC) 10 mg tablet aspirin 81 MG chewable tablet atorvastatin (LIPITOR) 40 mg tablet carbamide peroxide (DEBROX) 6.5 % otic solution carvedilol (COREG) 25 mg tablet cholecalciferol (VITAM
- Allergien
- SulfasalazineOther DiphenhydramineConfusion
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 85,0
- Geschlecht
- F
- Eingang
- 13.11.2023
- Impfdatum
- 26.09.2022
- Beginn
- 30.08.2023
- Tage bis Beginn
- 338,0
- Dosis
- N/A
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Blood creatinine increased
COVID-19
Chest X-ray normal
Hypoxia
Muscular weakness
Respiratory symptom
SARS-CoV-2 test positive
Upper respiratory tract infection
Symptomtext
BRIEF OVERVIEW: Admission Date: 8/30/2023 Discharge Date: Sep 2, 2023 Discharge Disposition: home health care svc ? DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] COVID-19 [U07.1] HOSPITAL COURSE: 86-year-old female with a past medical history significant for chronic kidney disease stage IIIB as well as known atrial tachycardia and hypertension who presents due to complaints of bilateral lower extremity weakness. Patient also notably had some complaints suspected related to upper respiratory infection. Patient is mildly hypoxic on admission with a 90% oxygen saturation on room air. Labs were remarkable for a creatinine of 1.35. COVID-19 testing came back positive. Chest x-ray showed no acute infiltrate. Patient was admitted to the hospital for further evaluation and treatment. Patient was initially placed on supplemental oxygen with 2 liters/minute and started on oral Decadron. Respiratory symptoms improve and patient was weaned off oxygen. Patient was discharged to complete 6 days total of oral Decadron. Patient was seen by PT and OT recommended home with home care. Patient was subsequent discharged home in medically stable condition.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Asthenia
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Atrial tachycardia (HCC) At risk for falls Stage 3b chronic kidney disease (HCC) Mixed hyperlipidemia Primary hypertension Generalized anxiety disorder Polyneuropathy History of benign spinal cord tumor Paraparesis of both lower limbs (HCC) Overactive bladder Osteopenia
- Andere Medikamente
- ALPRAZolam (XANAX) 0.25 MG tablet amLODIPine (NORVASC) 10 mg tablet aspirin 81 MG tablet Calcium Carbonate-Vit D-Min (RA CALCIUM 600/VIT D/MINERALS) 600-200 MG-UNIT TABS Cholecalciferol (VITAMIN D-3 PO) flecainide (TAMBOCOR) 50 mg tablet fu
- Allergien
- Amoxicillin OtherNausea Only PenicillinsUnknown SertralineNausea Only Sulfa Drugs
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 80,0
- Geschlecht
- M
- Eingang
- 03.01.2023
- Impfdatum
- 28.12.2022
- Beginn
- 28.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
fluzone high dose quadrivalent being administered post excursion with no reported adverse event; Initial information received on 30-Dec-2022 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 80 years old male patient who had vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] high dose quadrivalent being administered post excursion with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 28-Dec-2022, the patient received 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot number: UJ924AC and expiry date: 06-Jun-2023) via intramuscular route in left deltoid for immunisation. On 28-Dec-2022 the patient developed a non-serious fluzone high dose quadrivalent being administered post excursion with no reported adverse event (poor quality product administered)(latency: same day) following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE. Action taken: not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 43,0
- Geschlecht
- M
- Eingang
- 31.10.2022
- Impfdatum
- 28.10.2022
- Beginn
- 28.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
CLIENT WAS GIVEN THE WRONG FORMULATION OF INFLUENZA VACCINE. CLIENT WAS GIVEN THE FLUZONE HIGH-DOSE QUADRIVALENT AND SHOULD HAVE BEEN GIVEN THE FLULAVAL QUADRIVALENT.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- F
- Eingang
- 20.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 14.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
use of fluzone high dose to a 58 year old patient with no reported adverse event; Initial information received on 14-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 58 years old female patient and reported that there was use of fluzone high dose to a 58 year old patient with no reported adverse event, it involved vaccine INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were reported as none On 14-Oct-2022, the patient received a dose of 0.7 ml once of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE , with an unknown formulation and strength, (lot: UJ924AC ; expiry date: 30-Jun-2023)via intramuscular route in the left deltoid for immunization. It was reported that on 14-Oct-2022, there was use of Fluzone high dose to a 58 year old patient with no reported adverse event (product administered to patient of inappropriate age) (latency: same day). Action taken : not applicable. Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 74,0
- Geschlecht
- M
- Eingang
- 14.10.2022
- Impfdatum
- 12.10.2022
- Beginn
- 12.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Skin swelling
Throat irritation
Symptomtext
pt called on 10/13/2022, to report after one hour he had a really puffed up arm and he felt a scratchy throat. Took benadryl that evening and felt fine in the am. No redness at site or streaking. Provider notified.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Skin swelling
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- NDKA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 04.10.2022
- Impfdatum
- 04.10.2022
- Beginn
- 04.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
No sign/symptoms
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Ventolin inhaler Amitriptyline 25mg Ocrevus 300mg
- Allergien
- NKA
- Vorherige Impfungen
- -